EPISODE · Jun 27, 2024 · 21 MIN

sGC Activator Avenciguat for CKD

from Journal of the American Society of Nephrology (JASN) · host American Society of Nephrology

Dr. Hiddo J.L. Heerspink discusses the findings from his study, "Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials" with JASN Editor-in-Chief Rajnish Mehrotra.

Episode metadata supplied by the publisher feed · Published Jun 27, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

sGC Activator Avenciguat for CKD

0:00 21:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of the American Society of Nephrology (JASN)?

This episode is 21 minutes long.

When was this Journal of the American Society of Nephrology (JASN) episode published?

This episode was published on June 27, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Journal of the American Society of Nephrology (JASN) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!